Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors

Triple-negative breast cancer refers to breast cancer patients with negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2). Metastatic triple-negative breast cancer is predominantly treated with chemotherapy, but later-line treatment remains cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ruoyan, Qian, Jie, Shan, Mengjun, Ruan, Guangxin, Yang, Xiaofeng, Wang, Yanwen, Liu, Lingshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971810/
https://www.ncbi.nlm.nih.gov/pubmed/36865792
http://dx.doi.org/10.3389/fonc.2023.1023787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971810/
https://www.ncbi.nlm.nih.gov/pubmed/36865792
http://dx.doi.org/10.3389/fonc.2023.1023787

Ejemplares similares